ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,255.20
1.29%
Dow Jones
40,415.44
0.32%
Brent Oil
81.795
0.34%
Bitcoin
67,427.79
-0.26%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Astrazeneca Plc (AZN) Quote

Astrazeneca Plc

Astrazeneca Plc (AZN)

AstraZeneca PLC
AZN Capital Corp
12,260.00
154.00
(1.27%)
Closed July 22 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
12,260.00
Bid
12,256.00
Ask
12,260.00
Volume
1,924,876
12,194.00 Day's Range 12,356.00
9,461.00 52 Week Range 12,704.00
Market Cap
187.666B
Previous Close
12,106.00
Open
12,234.00
Last Trade
31
@
12260
(O)
Last Trade Time
Financial Volume
236,075,936p
VWAP
12,264.475
Average Volume (3m)
1,817,124
Shares Outstanding
1,550,189,338
Dividend Yield
1.86%
PE Ratio
31.91
Earnings Per Share (EPS)
3.84
Revenue
45.81B
Net Profit
5.96B

About Astrazeneca Plc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.astrazeneca.com
Headquarters
Cambridge, Gbr
Founded
1970
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,106p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,704.00p.

Astrazeneca currently has 1,550,189,338 shares outstanding. The market capitalization of Astrazeneca is £187.67 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.91.

AZN Latest News

More News

AstraZeneca PLC Acquisition of Amolyt Pharma completed

AstraZeneca PLC 15 July 2024   15 July 2024   Acquisition of Amolyt Pharma completed   AstraZeneca today announced the successful completion of the acquisition of Amolyt Pharma, a...

July 15 2024
RNS Regulatory News

TOP NEWS: AstraZeneca drug Tagrisso gets EU approval for cancer form

AstraZeneca PLC on Friday announced that its medication osimertinib, alongside chemotherapy, has been approved by the ...

July 05 2024
Alliance News

Aptamer shares jump as inks agreement with AstraZeneca

Aptamer Group PLC on Wednesday said it reached an agreement with AstraZeneca PLC. The York, England-based biotechnol ...

July 03 2024
Alliance News

AstraZeneca PLC Total Voting Rights

AstraZeneca PLC 01 July 2024   1 July 2024 15:00 BST     Transparency Directive Voting rights and capital   The following notification is made in accordance with the UK Financial Conduct...

July 01 2024
RNS Regulatory News

TOP NEWS: AstraZeneca cancer and Covid drugs recommended for approval

AstraZeneca PLC on Monday said two cancer treatments had been recommended for approval in the European Union, while t ...

July 01 2024
Alliance News

AstraZeneca PLC Lynparza & Imfinzi positive CHMP in endometrial

AstraZeneca PLC 01 July 2024     1 July 2024   Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for patients with mismatch repair proficient advanced or recurrent...

July 01 2024
RNS Regulatory News

TOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in China

AstraZeneca PLC on Wednesday celebrated the approval of Tagrisso plus chemotherapy for a cancer form in China, a day ...

June 26 2024
Alliance News

TOP NEWS: AstraZeneca details mixed findings from cancer drug trials

AstraZeneca PLC on Tuesday announced a mixed bag of results for two of its leading cancer drugs Imfinzi and Tagrisso. ...

June 25 2024
Alliance News

AstraZeneca PLC Update on Imfinzi ADJUVANT BR.31 trial

AstraZeneca PLC 25 June 2024   25 June 2024   Update on ADJUVANT BR.31 Phase III trial of Imfinzi in non-small cell lung cancer   High-level results from the ADJUVANT BR.31 Phase III trial...

June 25 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1520.425950196592122081238211924108648612146.551945DE
4-128-1.0332579916123881270411924134226212249.6758301DE
1260.0489636037212122541270411880181712412276.6410766DE
26179217.118838364510468127049461228785711099.4047791DE
52146013.518518518510800127049461216123210866.75279DE
156377744.52434280338483127048029216648310323.274545DE
260590392.8582664779635712704587122756939198.28854459DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
151.42M
CMAXCareMax Inc
$ 5.7101
(261.40%)
100.56M
NUKKNukkleus Inc
$ 0.5415
(69.22%)
24.87M
SNOASonoma Pharmaceuticals Inc
$ 0.423
(37.34%)
4.57M
LPSNLivePerson Inc
$ 1.2999
(31.30%)
8.57M
LGCBLinkage Global Inc
$ 3.6601
(-29.82%)
168k
CGBSCrown LNG Holdings Ltd
$ 0.9997
(-29.10%)
3.39M
SPECSpectaire Holdings Inc
$ 0.3962
(-24.53%)
1.87M
GSUNGolden Sun Health Technology Group Ltd
$ 5.13
(-23.66%)
158.79k
PSNLPersonalis Inc
$ 2.9808
(-22.58%)
3.11M
NVDANVIDIA Corporation
$ 123.54
(4.76%)
239M
SQQQProShares UltraPro Short QQQ
$ 8.09
(-4.37%)
183.65M
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
158.14M
SERVServe Robotics Inc
$ 8.73
(15.63%)
151.56M
NCPLNetcapital Inc
$ 0.1118
(7.50%)
124.37M

Discussion

View Full Feed
RSuave25020 RSuave25020 55 seconds ago
You make a very good point as well. I agree with that 100 percent. Let’s hope you are the more correct thinker here.
LQMT
BefallenKnight BefallenKnight 2 minutes ago
Dude you literally threatened to dox me for talking badly about your beloved RONN.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174746810 Remember this….. Pepperidge Farm remembers. And that link is merely one of your disturbing rants attacking or threatening me.
RONN
yman yman 2 minutes ago
https://www.cccba.org/article/preserving-employers-patent-rights-with-shop-rights-hired-to-invent-doctrines/
NNLX
mrwilson31 mrwilson31 3 minutes ago
Show me where I gave advice on when to buy here. Prove me wrong! Now is your chance. It’s pretty simple to figure out when to buy and sell down here on the OTC. Buy low- sell higher. It’s not that difficult.

Unless……it is for you!
XCRT
mick mick 4 minutes ago
HOLO
MicroCloud Hologram Inc
0.4657
-0.0724 (-13.45%)
Volume: 25,398,995
Day Range: 0.455 - 0.558
Bid: 0.4656
Ask: 0.465
Last Trade Time: 7:59:53 PM EDT
Total Trades: 31,138
HOLO
fuagf fuagf 4 minutes ago
You'd think they would scotch the no injury rumors. Apparently there are earlier photos around pushing what so far looks misinformation ..
https://apnews.com/article/fact-check-trump-shooting-ear-damage-photo-470220313611 .

One Kinzinger note:

https://twitter
chipboarder chipboarder 4 minutes ago
Yes I’m an old engineer (83) but I’ve seen many engineers try to launch ventures…..sometimes they even succeed. Technical people lack expertise in Marketing/Sales/Finance and are generally too narrow in their expertise. The exceptions (Musk, Jobs, Tesla, Hughes) fall somewhere on the autism scale
LQMT
Mr. Bill Mr. Bill 4 minutes ago
Hulk Hogan calls himself a coward - what a strong person!!!

https://www.brighteon.com/1472207e-b313-417a-ac62-f42ae7025126
Not likely Not likely 5 minutes ago
Your credibility has plummeted with your silly attempt at 'exposing' and blaming the bashers.

If this was legit the pumpers wouldn't be so concerned.

This is a scam bar none.


Not even a question.
SPZI
eastunder eastunder 5 minutes ago
Prediction: This Could Be the Best-Performing EV Stock Through 2030
Ryan Vanzo, The Motley Fool
Mon, Jul 22, 2024, 6:08 PM MDT5 min read

Electric vehicle (EV) stocks have been on a bumpy ride recently. But as Tesla's (NASDAQ: TSLA) journey proves, there's huge upside pot
RIVN TSLA
janice shell janice shell 6 minutes ago
https://x.com/reallyamerican1/status/1815498281889218843?s=42
irishintelligence irishintelligence 7 minutes ago
https://investorshub.advfn.com/boards/profilea.aspx?user=852059

Not likely, Alias Born 07/11/2024, 11 days ago. Welcome to the basher party. Maybe Koolaid or surfkast, or Huggy realized it was time for a fresh account to bash...
SPZI
janice shell janice shell 7 minutes ago
https://x.com/reallyamerican1/status/1815498281889218843?s=42
rodeoup rodeoup 7 minutes ago
They will have to pry my jaw open to get any of my shares, and I’m sitting on them until my arthritis gets too bad. Now for me I believe that in the 4th quarter when the gold bars really starts hitting the books that’s when the real price explosion and the push toward the sky’s should happen, and in
NBRI
Jonjones325 Jonjones325 8 minutes ago
Right I guess there’s no other choice.
AVXL
Susie924 Susie924 8 minutes ago
https://x.com/cmclymer/status/1815558867570307518?s=61&t=l6GKVEdo0Da_aaSoa8_4zw
Golden Cross Golden Cross 8 minutes ago
SPCB Latest News: SuperCom Secures Additional $2.9 Million in New Orders from European Governments to be Delivered Within Four Months
https://stocktitan.net/news/SPCB/super-com-secures-additional-2-9-million-in-new-orders-from-european-tdb9prw332dm.html#:~:text=SuperCom%20(NASDAQ%3A%20SPCB)%2
SPCB
mrwilson31 mrwilson31 9 minutes ago
I already told you that you give me my daily laughs. It’s my little fun. Look at my posts and tell me when so told people to buy or sell? I dare you to find one? Here is your chance to prove you are correct for once.

I come here for pure fun and folly at the bashers expense. Which yo
XCRT
irishintelligence irishintelligence 9 minutes ago
https://investorshub.advfn.com/boards/profile.aspx?user=427610

Homebrew, Alias Born: 10/29/2013, an equal opportunity basher. Does not even hide it.
SPZI
eastunder eastunder 9 minutes ago
Plug offering has closed/ estimates net proceeds $190.6 million - or $219 mil (If additional option to purchase exercised)

On July 18, 2024, Plug Power Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC, as represen
Not likely Not likely 9 minutes ago
Regardless of your resorting to weak basher propaganda...


This is a scam.
SPZI
here2help here2help 9 minutes ago
https://x.com/Deepinyomomma/status/1815504608208515092
SMCE
Golden Cross Golden Cross 10 minutes ago
$SPCB Latest News: SuperCom Secures Additional $2.9 Million in New Orders from European Governments to be Delivered Within Four Months
https://stocktitan.net/news/SPCB/super-com-secures-additional-2-9-million-in-new-orders-from-european-tdb9prw332dm.html#:~:text=SuperCom%20(NASDAQ%3A%20SPCB)%
SPCB

Your Recent History

LSE
AZN
Astrazeneca
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved